Operation TrialBlazer: Turning Policy into Progress with Guest Rob King
A roadmap can set the direction. What actually gets a clinical trial moving? In this episode of Fractals: Life Science Conversations , Rob King of Pivotal CRO joins Colin Miller to unpack Operation TrialBlazer—and ask whether its ambitions address the practical barriers slowing U.S. clinical research. With more than 30 years of experience across CROs, biotech, government, and academia, Rob brings a global perspective to the discussion: Why sponsors look beyond the U.S. for early-phase trials How site contracting can undermine efforts to accelerate development Why eligibility criteria deserve scrutiny before a protocol is finalized Where CROs need to challenge sponsors and contribute earlier How sponsors can distinguish actionable changes from proposals still taking shape A candid conversation about what it takes to turn policy ambitions into progress for sponsors, sites, and patients.





